Decreased expression of vitamin K epoxide reductase complex subunit 1 in kidney of patients with calcium oxalate urolithiasis

Abstract

Urinary prothrombin fragment 1 (UPTF1) is a potent inhibitor of urinary stone formation. UPTF1 exerts such inhibitory effect by effective γ-carboxylation in which vitamin K epoxide reductase complex subunit 1 (VKORC1), the rate-limiting enzyme, is involved. This study examined the correlation between VKORC1 expression and calcium oxalate urolithiasis. The renal cortex samples were obtained from patients undergoing nephrectomy and then divided into 3 groups: urolithiasis group, control group A [hydronephrosis-without-stone (HWS) group], control group B (normal control group). The localization and expression of VKORC1 in renal tissues were determined by using immunohistochemistry, immunofluorescence microscopy, Western blotting and SYBR Green I real-time reverse-transcription PCR. The rapid amplification of cDNA ends (RACE) were conducted to obtain the 3′- and 5′-untranslated region (UTR) of VKORC1. The results showed that VKORC1 was located in the cytoplasm of renal tubular epithelial cells. The expression of VKORC1 in the urolithiasis group was significantly lower than that in the other two control groups (P<0.05). Moreover, the 3′- and 5′-UTR sequence of the VKORC1 gene was successfully cloned. No insertion or deletion was found in the 3′- and 5′-UTR. However, a 171-bp new base sequence was discovered in the upstream of 5’-UTR end in the urolithiasis group. It was concluded that the decreased expression of VKORC1 may contribute to the development of calcium oxalate urolithiasis in the kidney.

Keywords

calcium oxalate urolithiasis / vitamin K epoxide reductase complex subunit 1 / vitamin K circle / urinary prothrombin fragment 1

References

[1] HallP.M.. Nephrolithiasis: treatment, causes, and prevention. Cleve Clin J Med, 2009, 76(10): 583-591

[2] WorcesterE.M., CoeF.L.. Clinical practice: calcium kidney stones. N Engl J Med, 2010, 363(10): 954-963

[3] KumarV., Peña de la VegaL., FarellG., et al.. Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kidney Int, 2005, 68(4): 1784-1792

[4] WaltonR.C., KavanaghJ.P., HeywoodB.R., et al.. The association of different urinary proteins with calcium oxalate hydromorphs. Evidence for non-specific interactions. Biochimica et Biophysica Acta (BBA), 2005, 1723(1): 175-183

[5] BasavarajD.R., BiyaniC.S., BrowningA.J., et al.. The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series, 2007, 5(3): 126-136

[6] KumarV., FarellG., LieskeJ.C.. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol, 2003, 170(1): 221-225

[7] GroverP.K., MiyazawaK., ColemanM., et al.. Renal prothrombin mRNA is significantly decreased in a hyper-oxaluric rat model of nephrolithiasis. J Pathol, 2006, 210(3): 273-281

[8] GroverP.K., RyallR.L.. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur J Biochem, 1999, 263(1): 50-56

[9] GroverP.K., RyallR.L.. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Clin Sci (Lond), 2002, 102(4): 425-434

[10] LiuJ., ChenJ., WangT., et al.. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus. J Urol, 2005, 173(1): 113-116

[11] GongX., GutalaR., JaiswalA.K.. Quinone oxidoreductases and vitamin K metabolism. Vitam Horm, 2008, 78(1): 85-101

[12] LivakK.J., SchmittgenT.D.. Analysis of relative gene expression data using realtime quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods, 2001, 25(4): 402-408

[13] StaffordD.W.. The vitamin K cycle. Thromb Haemost, 2005, 3(8): 1873-1878

[14] BerknerK.L., RungeK.W.. The physiology of vitamin nutriture and vitamin K-dependent protein function in aerosclerosis. Thromb Haemost, 2004, 2(12): 2118-2132

[15] GrayN.K., WickensM.. Control of translation initiation in animals. Annu Rev Cell Dev Biol, 1998, 14(1): 399-458

[16] SayerJ.A.. The genetics of nephrolithiasis. Nephron Exp Nephrol, 2008, 110(2): 37-43

This project was supported by a grant from the National Natural Science Foundation of China (No. 30901482).